PAR-25-230-Full-Announcement.html

This is a full grant announcement for PAR-25-230, which is a reissue of PAR-23-026 for Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed). The funding opportunity is administered by the Department of Health and Human Services' National Institutes of Health (NIH) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846).

The grant is open to a wide range of applicants including state and local governments, tribal organizations, higher education institutions, nonprofits, and small businesses. The announcement notes this is a reissue that incorporates Simplified Review changes in Section V, while maintaining all other aspects of the original funding opportunity. The program focuses on research related to causes, treatment, and prevention of arthritis, musculoskeletal and skin diseases, including training of basic and clinical scientists. Clinical trials are explicitly not allowed under this R21 grant mechanism.